Search research articles
Contact Us
Filters
Showing results (231-240 of 311) with videos related to
Page
of 32
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
January 17, 2026
Health Related Quality of Life after SBRT for Oligoprogressive Disease: Results from a Phase II Prospective Trial
Joelle Helou, Rachel Glicksman, Andrea Bezjak, et al.
Social Psychiatry and Psychiatric Epidemiology
|
October 13, 2023
Rates and correlates of medication non-adherence behaviors and attitudes in adult patients with early psychosis
Yuen Kiu So, Ching Yui Chan, Shi Cheng Fung, et al.
Gynecologic Oncology
|
September 11, 2020
Biomarkers of outcome to weekly paclitaxel in epithelial ovarian cancer
Ainhoa Madariaga, Swati Garg, Jeffrey P Bruce, et al.
Cancer
|
January 8, 2015
A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma
Mairéad G McNamara, Lisa W Le, Anne M Horgan, et al.
Immunotherapy
|
November 1, 2025
Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials
Courtney H Coschi, Keyue Ding, Dongsheng Tu, et al.
AJNR. American Journal of Neuroradiology
|
December 23, 2024
Perfusion Showdown: Comparison of Multiple MRI Perfusion Techniques in the Grading of Pediatric Brain Tumors
Chang Y Ho, Nucharin Supakul, Greg Anthony, et al.
Retina (Philadelphia, Pa.)
|
December 15, 2015
ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics
Alexa L Li, Charles C Wykoff, Rui Wang, et al.
The American Journal of Pathology
|
December 30, 2018
Peroxisome Proliferator-Activated Receptor-γ Knockdown Impairs Bone Morphogenetic Protein-2-Induced Critical-Size Bone Defect Repair
Chenchao Wang, Justine Tanjaya, Jia Shen, et al.
Plos One
|
December 14, 2016
MATE2 Expression Is Associated with Cancer Cell Response to Metformin
Sanjana Chowdhury, Eric Yung, Melania Pintilie, et al.
British Journal of Cancer
|
July 22, 2022
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer
Mark K Doherty, Vincent C Tam, Mairéad G McNamara, et al.
Page
of 32
Search research articles
Search
Showing results (231-240 of 311) with videos related to
Sort By:
Page
of 32
International Journal of Radiation Oncology, Biology, Physics
|
January 17, 2026
Health Related Quality of Life after SBRT for Oligoprogressive Disease: Results from a Phase II Prospective Trial
Joelle Helou, Rachel Glicksman, Andrea Bezjak, et al.
Social Psychiatry and Psychiatric Epidemiology
|
October 13, 2023
Rates and correlates of medication non-adherence behaviors and attitudes in adult patients with early psychosis
Yuen Kiu So, Ching Yui Chan, Shi Cheng Fung, et al.
Gynecologic Oncology
|
September 11, 2020
Biomarkers of outcome to weekly paclitaxel in epithelial ovarian cancer
Ainhoa Madariaga, Swati Garg, Jeffrey P Bruce, et al.
Cancer
|
January 8, 2015
A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma
Mairéad G McNamara, Lisa W Le, Anne M Horgan, et al.
Immunotherapy
|
November 1, 2025
Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials
Courtney H Coschi, Keyue Ding, Dongsheng Tu, et al.
AJNR. American Journal of Neuroradiology
|
December 23, 2024
Perfusion Showdown: Comparison of Multiple MRI Perfusion Techniques in the Grading of Pediatric Brain Tumors
Chang Y Ho, Nucharin Supakul, Greg Anthony, et al.
Retina (Philadelphia, Pa.)
|
December 15, 2015
ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics
Alexa L Li, Charles C Wykoff, Rui Wang, et al.
The American Journal of Pathology
|
December 30, 2018
Peroxisome Proliferator-Activated Receptor-γ Knockdown Impairs Bone Morphogenetic Protein-2-Induced Critical-Size Bone Defect Repair
Chenchao Wang, Justine Tanjaya, Jia Shen, et al.
Plos One
|
December 14, 2016
MATE2 Expression Is Associated with Cancer Cell Response to Metformin
Sanjana Chowdhury, Eric Yung, Melania Pintilie, et al.
British Journal of Cancer
|
July 22, 2022
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer
Mark K Doherty, Vincent C Tam, Mairéad G McNamara, et al.
Page
of 32